Related Experiment Video
Updated: Jul 30, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Gemcitabine-induced radiation recall dermatitis: case report.
G Bar-Sela1, A Beny, R Bergman
1Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa. bar_sela@rambam.health.gov.il
Tumori
|May 7, 2002
Summary
A patient developed radiation recall dermatitis after receiving gemcitabine chemotherapy for lung adenocarcinoma. This rare side effect highlights a potential interaction between radiotherapy and gemcitabine.
Area of Science:
- Oncology
- Dermatology
- Radiotherapy
Background:
- Lung adenocarcinoma is a common cancer.
- Radiotherapy and chemotherapy are standard treatments.
- Radiation recall dermatitis is an uncommon reaction.
Observation:
- A 65-year-old male with lung adenocarcinoma underwent radiotherapy and gemcitabine chemotherapy.
- The patient developed radiation recall dermatitis within the radiotherapy port.
Findings:
- Gemcitabine chemotherapy triggered radiation recall dermatitis.
- This case is among few reported instances of gemcitabine-induced radiation recall dermatitis.
Implications:
- Clinicians should be aware of gemcitabine's potential to cause radiation recall dermatitis.
- Further research is needed to understand this interaction.
- This finding may impact treatment protocols for lung adenocarcinoma.
